ArticleMolecular cancer therapeutics2015

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells.

Bryan Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.